Fortive Corporation: Truist Securities cuts target price to $63 from $68
FTV•Truist Securities cut its target price for Fortive Corporation to $63 from $68.
Related News
Revolution Medicines starts Phase 3 trial of RASONQUE-zoldonrasib combo in first-line metastatic RAS G12D pancreatic cancer
RVMD•
Texas Roadhouse rises after Evercore ISI upgrades stock rating to 'outperform'
TXRH•
Catalent launches accelerated gene-to-drug substance program for complex molecules in U.S.
CTLT•
Stablecoin Development Corp completes private placement worth about $134 million
SDEV•
Leidos, Altaris close Analogic security screening joint venture deal
LDOS•